# Phase III Clinical Trial of Sabin Strain Inactivated Poliovirus Vaccine (Vero Cell)

> **NCT07297186** · PHASE3 · COMPLETED · sponsor: **Beijing Minhai Biotechnology Co., Ltd** · enrollment: 1200 (actual)

## Conditions studied

- Poliomyelitis

## Interventions

- **BIOLOGICAL:** sIPV
- **BIOLOGICAL:** wIPV

## Key facts

- **NCT ID:** NCT07297186
- **Lead sponsor:** Beijing Minhai Biotechnology Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-08-21
- **Primary completion:** 2023-04-10
- **Final completion:** 2023-04-10
- **Target enrollment:** 1200 (ACTUAL)
- **Last updated:** 2025-12-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07297186

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07297186, "Phase III Clinical Trial of Sabin Strain Inactivated Poliovirus Vaccine (Vero Cell)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT07297186. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*